Sunrise, a Namur, Belgium-based company which specializes in home sleep diagnostics, raised $6M in funding.
The round saw participation from Alexa Fund and French healthcare investor UI-Investissement (Majycc Innovation Santé), for a total of $24M raised this year.
The company intends to use the funds to further expand its reach.
Led by CEO Laurent Martinot, Sunrise is advancing accurate and reliable and user-friendly sleep diagnostics, both for patients and healthcare providers. By focusing on these jaw movements, the company delivers a high-precision tool for sleep diagnosis via an 8-gram sensor comfortably placed on the chin. On top of that, Sunrise measures ‘respiratory effort,’ a commonly overlooked metric in home sleep tests. This allows for the distinction between central and obstructive sleep apnea. It also offers new metrics like ‘respiratory effort burden,’ linked to fatigue, type II diabetes, and hypertension. Such detailed insights pave the way for personalized treatments and better health outcomes for those facing sleep challenges.
Sunrise has additional offices in France and the United States. It obtained two FDA approvals in the United States, and the renewed CE certification under MDR in Europe.
FinSMEs
14/11/2023